Walgreens settles New York charges it grossly inflated prices of infant
formula
Send a link to a friend
[March 12, 2024]
By Jonathan Stempel
NEW YORK (Reuters) -Walgreens has settled charges by New York Attorney
General Letitia James that it grossly inflated prices on at least 20
infant formula products after a recall by Abbott Labs led to a
nationwide shortage in early 2022.
The largest U.S. pharmacy chain did not admit or deny wrongdoing in
entering an assurance of discontinuance with James' office, including a
$50,000 payment covering civil penalties and costs, that was made public
on Monday.
James said Walgreens raised prices on the 20 products, including
Abbott's Similac and Reckitt Benckiser's Enfamil, by 10% or more
following the February 2022 recall, and in at least one case boosted
formula prices by more than 70%.
Walgreens allegedly sold more than 3,400 cans or bottles or formula at
the "unconscionably" inflated prices.
Without admitting or denying wrongdoing, Walgreens agreed not to charge
excessive prices on consumer goods and services vital and necessary to
people's health and safety.
The Deerfield, Illinois-based company also agreed to donate 9,564
canisters of formula to benefit low-income New Yorkers with infant
children.

[to top of second column]
|

People walk by a Walgreens, owned by the Walgreens Boots Alliance,
Inc., in Manhattan, New York City, U.S., November 26, 2021.
REUTERS/Andrew Kelly/File Photo
 Walgreens declined to comment.
"During the formula shortage, families were panicked and struggling
about how to feed their babies," James said in a statement. "For
Walgreens to take advantage of this crisis and jack up formula
prices is not only illegal, but downright shameful.
"My office will not tolerate any company that attempts to price
gouge our state's consumers," she added.
The settlement was effective as of March 7, and signed by a
Walgreens representative on Monday.
Abbott recalled its infant formula and closed its Sturgis, Michigan
plant following reports that infants became sick after being fed
formula that was produced there. The company reopened the plant that
July.
(Reporting by Jonathan Stempel in New York; Editing by Chris Reese
and Stephen Coates)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |